CoChat

Effects of pioglitazone and metformin on β-cell function in nondiabetic subjects at high risk for type 2 diabetes

Rasouli, Neda, Kern, Philip A, Reece, E. Albert, Elbein, Steven C. · 2007 · American Journal of Physiology-Endocrinology and Metabolism
Cited by 23

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Thiazolidinediones (TZDs) and metformin decreased the incidence of diabetes in subjects at risk for developing diabetes and improved peripheral or hepatic insulin sensitivity, respectively. Whether they also directly improved β-cell function is not clear. In vitro studies showed improved β-cell function in response to TZDs and metformin; however, the effects of TZDs or metformin on β-cell function in humans are still uncertain. We hypothesized that both TZDs and metformin directly affect β-cell function. We evaluated β-cell function and insulin sensitivity (S I) in subjects with impaired glucose tolerance or a history of gestational diabetes using oral and intravenous glucose tolerance tests in addition to the glucose-potentiated arginine stimulation test. In contrast to metformin, pioglitazone improved S I, glucose tolerance, and insulin-independent glucose disposal [glucose effectiveness (S G)]. Neither pioglitazone nor metformin significantly improved β-cell compensation for insulin resistance [disposition index (DI)], but the change in DI significantly correlated with baseline S I. Insulin secretion in response to arginine at maximally potentiating glucose levels (AIR max) tended to increase after metformin and to decrease after pioglitazone; however, when adjusted for S I, the changes were not significant. Our results demonstrate that, in nondiabetic subjects at risk for diabetes, pioglitazone, but not metformin, significantly improved glucose tolerance by improving S I and S G. We did not find any evidence that either pioglitazone or metformin improved β-cell function. Improved β-cell compensation was observed primarily in the subgroup of subjects that had the lowest S I at baseline.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1152/ajpendo.00221.2006

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 23

Metadata

Authors
Rasouli, N., Kern, P. A., Reece, E. A., & Elbein, S. C.
Venue
American Journal of Physiology-Endocrinology and Metabolism
Published
2007-01
Volume
292
Issue
1
Pages
E359-E365
ISSN
  • 0193-1849 (ISSN-L)
  • 1522-1555
OpenAlex
W2140183516
Cited by
23
References
14
FWCI
1.21
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of pioglitazone and metformin on β-cell function in nondiabetic subjects at high risk for type 2 diabetes. https://app.cochat.ai/papers/10.1152/ajpendo.00221.2006
The paper
Rasouli, N., Kern, P. A., Reece, E. A., & Elbein, S. C. (2007). Effects of pioglitazone and metformin on β-cell function in nondiabetic subjects at high risk for type 2 diabetes. American Journal of Physiology-Endocrinology and Metabolism. https://doi.org/10.1152/ajpendo.00221.2006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.